Analysis of Axon Enterprise's Stock Price Decline
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 14 minutes ago
0mins
Should l Buy AXON?
Source: NASDAQ.COM
- Stock Price Decline Reasons: Axon Enterprise's shares have been on a downward trend since late 2025, dropping around 30% this year, primarily due to the market's rotation away from the SaaS sector and specific valuation concerns regarding the company.
- Rising Stock-Based Compensation: In 2025, Axon's stock-based compensation expenses totaled $610.1 million, a nearly 60% increase from 2024, with forecasts indicating that this will remain high in 2026, exerting pressure on the company's financial health.
- Valuation Issues: Currently, Axon trades at about 53 times forward earnings; while some fast-growing SaaS companies have similar valuations, disappointing earnings could trigger further sell-offs, raising concerns among investors.
- Future Uncertainties: With Axon's upcoming earnings report in May, market expectations regarding its future profitability are uncertain, which could lead to further declines in stock price, prompting investors to carefully consider their entry points.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AXON?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AXON
Wall Street analysts forecast AXON stock price to rise
15 Analyst Rating
14 Buy
1 Hold
0 Sell
Strong Buy
Current: 406.310
Low
610.00
Averages
800.38
High
925.00
Current: 406.310
Low
610.00
Averages
800.38
High
925.00
About AXON
Axon Enterprise, Inc. is a technology company that provides integrated hardware and software solutions. The Company's products and services allow customers across the public and private sector to capture and use critical data to support fully-connected operational workflows. The Software and Services segment include the development, manufacturing and sale of cloud-based Software-as-a-Service (SaaS) solutions that leverage AI and enable its customers to capture, securely store, manage, share and analyze video and other digital evidence. Its offerings include Axon Evidence, Draft One, Axon Records, Axon Standards, Axon Fusus, and Axon Assistant, among others. Its Connected Devices segment develops, manufactures and sells fully integrated hardware solutions such as conducted energy devices (CEDs) sold under the TASER brand, body cameras, fixed and in-car cameras, drone and counter-drone technologies, and a broad ecosystem of accessories, extended warranties and related hardware products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Analysis of Axon Enterprise's Stock Price Decline
- Stock Price Decline Reasons: Axon Enterprise's shares have been on a downward trend since late 2025, dropping around 30% this year, primarily due to the market's rotation away from the SaaS sector and specific valuation concerns regarding the company.
- Rising Stock-Based Compensation: In 2025, Axon's stock-based compensation expenses totaled $610.1 million, a nearly 60% increase from 2024, with forecasts indicating that this will remain high in 2026, exerting pressure on the company's financial health.
- Valuation Issues: Currently, Axon trades at about 53 times forward earnings; while some fast-growing SaaS companies have similar valuations, disappointing earnings could trigger further sell-offs, raising concerns among investors.
- Future Uncertainties: With Axon's upcoming earnings report in May, market expectations regarding its future profitability are uncertain, which could lead to further declines in stock price, prompting investors to carefully consider their entry points.
See More
Analysis of Axon Enterprise's Stock Price Decline
- SaaS Market Impact: Axon Enterprise's shares have been on a downward trend since late 2025, dropping around 30% in 2026 alone, primarily due to the market's rotation away from the SaaS sector, which has diminished investor confidence in its future growth prospects.
- High Stock-Based Compensation Pressure: The company's stock-based compensation expenses reached $610.1 million in 2025, a nearly 60% increase year-over-year, with forecasts for 2026 remaining in the $590 million to $620 million range, which continues to exert pressure on profitability and shareholder confidence.
- Valuation Concerns Intensify: Currently trading at approximately 53 times forward earnings, Axon faces valuation concerns similar to other fast-growing SaaS companies; however, if earnings disappoint, it could trigger another sell-off, further depressing the stock price.
- Uncertain Future Outlook: While forecasts suggest Axon's earnings could quadruple between 2026 and 2028, unforeseen events such as government budget cuts or policy changes could adversely affect performance, prompting investors to carefully consider whether to buy at this juncture.
See More
Analysis of Factors Dragging Down Axon Enterprise Stock
- SaaS Market Impact: Axon Enterprise's stock has dropped approximately 30% since late 2025, primarily due to a general market sell-off in the SaaS sector, particularly concerns about AI technology's potential disruption to subscription software services, leading investors to discard Axon alongside SaaS stocks.
- Surging Stock Compensation Costs: In 2025, Axon's stock-based compensation expenses reached $610.1 million, a nearly 60% increase from 2024, with expectations to remain between $590 million and $620 million in 2026, exacerbating market concerns over the company's valuation and potentially leading to further stock price declines.
- Earnings Expectations and Market Reaction: Despite Axon exceeding earnings expectations and providing optimistic guidance in its recent report, the stock failed to sustain a rebound, reflecting insufficient investor confidence in the company's future earnings growth, especially amid high valuations and uncertainty.
- Investor Strategy Adjustment: Given Axon's high valuation and potential future policy changes, investors may prefer to wait for a more attractive entry point, particularly ahead of the upcoming earnings report, as the market may exert additional pressure on the stock price.
See More
Palantir and Axon: AI Value Chain Insights
- Palantir's Market Potential: Palantir's stock is priced at $143 per share, with Wall Street's median target price at $200, indicating a 40% upside, reflecting the market's recognition of its crucial role in enterprise AI platforms.
- Strong Financial Performance: In Q4, Palantir's revenue surged 70% to $1.4 billion, with non-GAAP net income rising 79% to $0.25 per share, showcasing its ongoing business acceleration and robust market demand.
- Axon's Growth Outlook: Axon's stock is priced at $397, with a median target price of $700 from Wall Street, suggesting a 76% upside, highlighting its leadership in public safety products and strong AI integration capabilities.
- Signals of Sustained Demand: Axon reported a 39% increase in sales to $797 million in Q4, with non-GAAP net income soaring 84% to $2.15 per share, and contracted bookings rising 43% to $14.4 billion, indicating durable demand for its products.
See More
Palantir and Axon's AI Market Prospects
- Palantir Growth Potential: Palantir's revenue surged 70% in Q4 to $1.4 billion, marking its tenth consecutive quarter of acceleration, underscoring its critical role in enterprise AI platforms, although its P/E ratio of 190 indicates high market expectations for future growth.
- Axon Financial Performance: Axon reported a 39% increase in Q4 sales to $797 million, with non-GAAP net income soaring 84% to $2.15 per share, demonstrating strong demand and sustained growth potential in the public safety products market.
- Market Expectation Divergence: While Palantir's target price of $200 per share suggests a 40% upside, Axon's target price of $700 implies a 76% upside, reflecting differing market perceptions of the two companies.
- AI Integration Strategy: Axon is integrating AI technology into its law enforcement hardware and software to enhance efficiency, while Palantir leverages its AI platform to facilitate data-driven decision-making, showcasing both companies' strategic positioning in the AI sector.
See More
Palantir and Axon's AI Potential Analysis
- Palantir's Stock Potential: Wall Street analysts consider Palantir's stock undervalued at $143 per share, with a target price of $200, indicating a 40% upside, reflecting market recognition of its leadership in enterprise AI platforms.
- Strong Financial Performance: Palantir's revenue surged 70% in Q4 to $1.4 billion, with non-GAAP net income rising 79% to $0.25 per share, showcasing its robust execution in AI integration and analytics tools, although its P/E ratio of 190 times necessitates meeting high market expectations.
- Axon's Market Leadership: Axon excels in public safety products, with sales increasing 39% to $797 million and non-GAAP net income soaring 84% to $2.15 per share, indicating strong demand in the law enforcement and enterprise sectors.
- Future Growth Outlook: Axon's contracted bookings rose 43% to $14.4 billion, with adjusted earnings expected to grow at 24% annually through 2027, making its current P/E ratio of 55 times appear reasonable, as analysts have frequently underestimated the company's potential, presenting an attractive long-term investment opportunity.
See More
Analysis of Axon Enterprise's Stock Price Decline
- Stock Price Decline Reasons: Axon Enterprise's shares have been on a downward trend since late 2025, dropping around 30% this year, primarily due to the market's rotation away from the SaaS sector and specific valuation concerns regarding the company.
- Rising Stock-Based Compensation: In 2025, Axon's stock-based compensation expenses totaled $610.1 million, a nearly 60% increase from 2024, with forecasts indicating that this will remain high in 2026, exerting pressure on the company's financial health.
- Valuation Issues: Currently, Axon trades at about 53 times forward earnings; while some fast-growing SaaS companies have similar valuations, disappointing earnings could trigger further sell-offs, raising concerns among investors.
- Future Uncertainties: With Axon's upcoming earnings report in May, market expectations regarding its future profitability are uncertain, which could lead to further declines in stock price, prompting investors to carefully consider their entry points.
See More
Analysis of Axon Enterprise's Stock Price Decline
- SaaS Market Impact: Axon Enterprise's shares have been on a downward trend since late 2025, dropping around 30% in 2026 alone, primarily due to the market's rotation away from the SaaS sector, which has diminished investor confidence in its future growth prospects.
- High Stock-Based Compensation Pressure: The company's stock-based compensation expenses reached $610.1 million in 2025, a nearly 60% increase year-over-year, with forecasts for 2026 remaining in the $590 million to $620 million range, which continues to exert pressure on profitability and shareholder confidence.
- Valuation Concerns Intensify: Currently trading at approximately 53 times forward earnings, Axon faces valuation concerns similar to other fast-growing SaaS companies; however, if earnings disappoint, it could trigger another sell-off, further depressing the stock price.
- Uncertain Future Outlook: While forecasts suggest Axon's earnings could quadruple between 2026 and 2028, unforeseen events such as government budget cuts or policy changes could adversely affect performance, prompting investors to carefully consider whether to buy at this juncture.
See More
Analysis of Factors Dragging Down Axon Enterprise Stock
- SaaS Market Impact: Axon Enterprise's stock has dropped approximately 30% since late 2025, primarily due to a general market sell-off in the SaaS sector, particularly concerns about AI technology's potential disruption to subscription software services, leading investors to discard Axon alongside SaaS stocks.
- Surging Stock Compensation Costs: In 2025, Axon's stock-based compensation expenses reached $610.1 million, a nearly 60% increase from 2024, with expectations to remain between $590 million and $620 million in 2026, exacerbating market concerns over the company's valuation and potentially leading to further stock price declines.
- Earnings Expectations and Market Reaction: Despite Axon exceeding earnings expectations and providing optimistic guidance in its recent report, the stock failed to sustain a rebound, reflecting insufficient investor confidence in the company's future earnings growth, especially amid high valuations and uncertainty.
- Investor Strategy Adjustment: Given Axon's high valuation and potential future policy changes, investors may prefer to wait for a more attractive entry point, particularly ahead of the upcoming earnings report, as the market may exert additional pressure on the stock price.
See More
Palantir and Axon: AI Value Chain Insights
- Palantir's Market Potential: Palantir's stock is priced at $143 per share, with Wall Street's median target price at $200, indicating a 40% upside, reflecting the market's recognition of its crucial role in enterprise AI platforms.
- Strong Financial Performance: In Q4, Palantir's revenue surged 70% to $1.4 billion, with non-GAAP net income rising 79% to $0.25 per share, showcasing its ongoing business acceleration and robust market demand.
- Axon's Growth Outlook: Axon's stock is priced at $397, with a median target price of $700 from Wall Street, suggesting a 76% upside, highlighting its leadership in public safety products and strong AI integration capabilities.
- Signals of Sustained Demand: Axon reported a 39% increase in sales to $797 million in Q4, with non-GAAP net income soaring 84% to $2.15 per share, and contracted bookings rising 43% to $14.4 billion, indicating durable demand for its products.
See More
Palantir and Axon's AI Market Prospects
- Palantir Growth Potential: Palantir's revenue surged 70% in Q4 to $1.4 billion, marking its tenth consecutive quarter of acceleration, underscoring its critical role in enterprise AI platforms, although its P/E ratio of 190 indicates high market expectations for future growth.
- Axon Financial Performance: Axon reported a 39% increase in Q4 sales to $797 million, with non-GAAP net income soaring 84% to $2.15 per share, demonstrating strong demand and sustained growth potential in the public safety products market.
- Market Expectation Divergence: While Palantir's target price of $200 per share suggests a 40% upside, Axon's target price of $700 implies a 76% upside, reflecting differing market perceptions of the two companies.
- AI Integration Strategy: Axon is integrating AI technology into its law enforcement hardware and software to enhance efficiency, while Palantir leverages its AI platform to facilitate data-driven decision-making, showcasing both companies' strategic positioning in the AI sector.
See More
Palantir and Axon's AI Potential Analysis
- Palantir's Stock Potential: Wall Street analysts consider Palantir's stock undervalued at $143 per share, with a target price of $200, indicating a 40% upside, reflecting market recognition of its leadership in enterprise AI platforms.
- Strong Financial Performance: Palantir's revenue surged 70% in Q4 to $1.4 billion, with non-GAAP net income rising 79% to $0.25 per share, showcasing its robust execution in AI integration and analytics tools, although its P/E ratio of 190 times necessitates meeting high market expectations.
- Axon's Market Leadership: Axon excels in public safety products, with sales increasing 39% to $797 million and non-GAAP net income soaring 84% to $2.15 per share, indicating strong demand in the law enforcement and enterprise sectors.
- Future Growth Outlook: Axon's contracted bookings rose 43% to $14.4 billion, with adjusted earnings expected to grow at 24% annually through 2027, making its current P/E ratio of 55 times appear reasonable, as analysts have frequently underestimated the company's potential, presenting an attractive long-term investment opportunity.
See More
